Your browser doesn't support javascript.
loading
Exome Sequencing Identifies Genetic Variants Associated with Extreme Manifestations of the Cardiovascular Phenotype in Marfan Syndrome.
Jimenez, Yanireth; Paulsen, Cesar; Turner, Eduardo; Iturra, Sebastian; Cuevas, Oscar; Lay-Son, Guillermo; Repetto, Gabriela M; Rojas, Marcelo; Calderon, Juan F.
Afiliação
  • Jimenez Y; Doctorado en Ciencias e Innovación en Medicina, Facultad de Medicina Clínica Alemana Universidad del Desarrollo, Santiago 8320000, Chile.
  • Paulsen C; Servicio de Cirugía Cardiovascular, Instituto Nacional del Tórax, Santiago 7500808, Chile.
  • Turner E; Servicio de Cirugía Cardiovascular, Instituto Nacional del Tórax, Santiago 7500808, Chile.
  • Iturra S; Servicio de Cirugía Cardiovascular, Instituto Nacional del Tórax, Santiago 7500808, Chile.
  • Cuevas O; Servicio de Cirugía Cardiovascular, Instituto Nacional del Tórax, Santiago 7500808, Chile.
  • Lay-Son G; Departamento de Cirugía Cardiovascular, Clínica Alemana, Universidad del Desarrollo, Santiago 8320000, Chile.
  • Repetto GM; Unidad de Genética, División de Pediatría, Facultad de Medicina, Pontificia Universidad Católica de Chile, Santiago 8331150, Chile.
  • Rojas M; Programa de Enfermedades Poco Frecuentes, Centro de Genética y Genómica, Instituto de Ciencias e Innovación en Medicina, Facultad de Medicina Clínica Alemana Universidad del Desarrollo, Santiago 8320000, Chile.
  • Calderon JF; Doctorado en Ciencias e Innovación en Medicina, Facultad de Medicina Clínica Alemana Universidad del Desarrollo, Santiago 8320000, Chile.
Genes (Basel) ; 13(6)2022 06 08.
Article em En | MEDLINE | ID: mdl-35741789
Marfan Syndrome (MFS) is an autosomal dominant condition caused by variants in the fibrillin-1 (FBN1) gene. Cardinal features of MFS include ectopia lentis (EL), musculoskeletal features and aortic root aneurysm and dissection. Although dissection of the ascending aorta is the main cause of mortality in MFS, the clinical course differs considerably in age of onset and severity, even among individuals who share the same causative variant, suggesting the existence of additional genetic variants that modify the severity of the cardiovascular phenotype in MFS. We recruited MFS patients and classified them into severe (n = 8) or mild aortic phenotype (n = 14) according to age of presentation of the first aorta-related incident. We used Exome Sequencing to identify the genetic variants associated with the severity of aortic manifestations and we performed linkage analysis where suitable. We found five genes associated with severe aortic phenotype and three genes that could be protective for this phenotype in MFS. These genes regulate components of the extracellular matrix, TGFß pathway and other signaling pathways that are involved in the maintenance of the ECM or angiogenesis. Further studies will be required to understand the functional effect of these variants and explore novel, personalized risk management and, potentially, therapies for these patients.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Síndrome de Marfan Tipo de estudo: Risk_factors_studies Limite: Humans Idioma: En Revista: Genes (Basel) Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Chile

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Síndrome de Marfan Tipo de estudo: Risk_factors_studies Limite: Humans Idioma: En Revista: Genes (Basel) Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Chile